BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2364867)

  • 21. [Analysis of DNA of renal cell carcinomas by flow cytometry].
    Chassevent A
    Arch Anat Cytol Pathol; 1992; 40(5-6):307-11. PubMed ID: 1304118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection.
    Sasaki Y; Homma Y; Hosaka Y; Tajima A; Aso Y
    Jpn J Clin Oncol; 1994 Feb; 24(1):32-6. PubMed ID: 8126918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
    Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
    Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic parameters of renal cell carcinoma. Clinicopathologic and DNA image cytometric analysis in 133 pT3a cases.
    Steinbach F; Stöckle M; Kiewel R; Störkel S; Stein R; Hohenfellner R
    Eur Urol; 1993; 24(2):279-85. PubMed ID: 8375451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
    Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
    Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
    al-Abadi H; Nagel R
    Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.
    Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Passebosc-Faure K; Genin C; Tostain J
    In Vivo; 2002; 16(5):341-4. PubMed ID: 12494875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content.
    el-Naggar AK; Batsakis JG; Teague K; Giacco G; Guinee VF; Swanson D
    Am J Pathol; 1990 Aug; 137(2):275-80. PubMed ID: 2386196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor spread and DNA content in human renal cell carcinoma.
    Ljungberg B; Stenling R; Roos G
    Cancer Res; 1988 Jun; 48(11):3165-7. PubMed ID: 3365699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor heterogeneity of renal cell carcinoma as analyzed by flow cytometry].
    Nagamori S
    Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):593-600. PubMed ID: 2374332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flow cytometric DNA analysis of renal cell carcinoma and its relationship to tumor grading, tumor stage and prognosis].
    Hara H; Tanioka F
    Rinsho Byori; 1993 Jun; Suppl 94():76-88. PubMed ID: 8361010
    [No Abstract]   [Full Text] [Related]  

  • 33. Flow-cytometric analysis of the DNA content in paraffin-embedded tissue and in fresh tumour samples obtained from renal cell carcinoma: comparison of DNA ploidy using ethidium bromide and mithramycin.
    Fischer C; Knaust KO; Schauer A; Ringert RH
    Anticancer Res; 1996; 16(5A):2575-80. PubMed ID: 8917354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
    Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
    Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
    Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
    Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of flow cytometry in the prognosis of tumors of the kidney in adults].
    Sibert L; Laquerrière A; Czernichow P; Dadoun D; Hemet J; Grise P
    Ann Urol (Paris); 1989; 23(6):476-81. PubMed ID: 2694924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
    Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
    Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA cytometry in renal cell carcinoma.
    Nenning H; Rassler J; Minh DH
    Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.